One Carbon Therapeutics has been selected to present the MTHFD1/2 project to the International Board of MATWIN on May 10-11 th

We are excited to discuss our science and program with major pharma leaders.

Solna, Sweden, May 29th, 2026. One-carbon Therapeutics AB, a clinical-stage

Solna, Sweden, May 21, 2026. One-carbon Therapeutics AB, a clinical-stage